Investor Relations

News Releases

<< Back
Apr 17, 2018
Intersect ENT to Present at Deutsche Bank and Bank of America Merrill Lynch Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--Apr. 17, 2018-- Intersect ENT, Inc. (Nasdaq: XENT) today announced that management will present at Deutsche Bank’s 43rd Annual Health Care Conference and at Bank of America Merrill Lynch 2018 Healthcare Conference.

The Deutsche Bank Conference presentation is scheduled for May 9, 2018 at 10:40am EDT at the Boston InterContinental Hotel and the Bank of America Merrill Lynch presentation is scheduled for May 16, 2018 at 4:00pm EDT at the Encore at The Wynn in Las Vegas.

A webcast of both presentations will be available online from the Investor Relations page of the company’s website at www.IntersectENT.com. The webcast replays will be available for approximately one month.

About Intersect ENT®

Intersect ENT is dedicated to transforming ear, nose and throat care by providing innovative, clinically meaningful therapies to physicians and patients. The company’s steroid releasing implants are designed to provide mechanical spacing and deliver targeted therapy to the site of disease. In addition, Intersect ENT is continuing to expand its portfolio of products based on the company’s unique localized steroid releasing technology and is committed to broadening patient access to less invasive and more cost-effective care.

For additional information on the company or its products, including risks and benefits, please visit www.IntersectENT.com.

XENT-F

Source: Intersect ENT, Inc.

Intersect ENT
Jeri Hilleman, 650-641-2105
ir@intersectENT.com